4. Milestone $ 5. Milestone $ 6. Milestone $ due on Effective Date 3.1(c) Scheduled license fee payments due on due on __% of Non-Royalty Sublicensing Consideration 3.1d) Sublicense Fees $ 3.1(e) Assignment fee % 3.2 Running royalty (a) Licensed Products and Licensed Services rate (applies to covered by a Valid Claim Sales by Licensee, % (b) Licensed Products and Licensed Services Affiliates and not covered by a Valid Claim Sublicensees) 3.3 Minimum royalty for Contract Year ending for Contract Year ending per Contract Year thereafter [Include if applicable] 3.5 Equity Consideration 18. Contact Information Licensee Contacts Licensor Contacts Contact for Notice: Contact for Notice: Attn: [Name] Attn: [Name] [Address] [Address] Fax: [Fax number] Fax: [Fax number] Phone: [Phone number] Phone: [Phone number] E-mail: [E-mail] E-mail: [E-mail] Accounting contact: Payment and reporting contact: Attn: [Name] Checks payable to “_________” Attn: [Name] [Address] [Address] Fax: [Fax number] Fax: [Fax number] Phone: [Phone number] [Phone number] E-mail: [E-mail] E-mail: [E-mail] Patent prosecution contact: Attn: [Name] Patent prosecution contact: Attn: [Name] [Address] [Address] Fax: [Fax number] Fax: [Fax number] [Phone number] Phone: [Phone number] E-mail: [E-mail] E-mail: [E-mail] For Licensor Administrative Purposes Only Changes to Standard There have not been any revisions to Licensor’s standard form Form Terms and Terms and Conditions , except for revisions to the following Conditions sections: [insert section numbers or “none”]
4. Milestone $ 5. Milestone $ 6. Milestone $ 3.1(c) Scheduled license fee payments due on Effective Date due on due on 3.1d) Sublicense Fees __% of Non-Royalty Sublicensing Consideration 3.1(e) Assignment fee $ 3.2 Running royalty rate (applies to Sales by Licensee, Affiliates and Sublicensees) (a) Licensed Products and Licensed Services covered by a Valid Claim % (b) Licensed Products and Licensed Services not covered by a Valid Claim % 3.3 Minimum royalty for Contract Year ending for Contract Year ending per Contract Year thereafter 3.5 Equity Consideration [Include if applicable] 18. Contact Information Licensee Contacts Licensor Contacts Contact for Notice: Attn: [Name] [Address] Fax: [Fax number] Phone: [Phone number] E-mail: [E-mail] Accounting contact: Attn: [Name] [Address] Fax: [Fax number] Phone: [Phone number] E-mail: [E-mail] Patent prosecution contact: Attn: [Name] [Address] Fax: [Fax number] [Phone number] E-mail: [E-mail] Contact for Notice: Attn: [Name] [Address] Fax: [Fax number] Phone: [Phone number] E-mail: [E-mail] Payment and reporting contact: Checks payable to “_________” Attn: [Name] [Address] Fax: [Fax number] [Phone number] E-mail: [E-mail] Patent prosecution contact: Attn: [Name] [Address] Fax: [Fax number] Phone: [Phone number] E-mail: [E-mail] For Licensor Administrative Purposes Only Changes to Standard Form Terms and Conditions There have not been any revisions to Licensor’s standard form Terms and Conditions , except for revisions to the following sections: [insert section numbers or “none”]
patent-license-agreement-lifesci-template-two-part-2010-03-2.docx